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Abstract
Background: Clinical practice guidelines recommend that all medical providers address tobacco use with
patients, as the long-term health benefits of becoming tobacco free are well documented. What happens, though,
when a patient has an incurable malignancy and, therefore, will not reap the long-term benefits?
Clinical Consideration: Our case study encourages providers to consider the relevance of tobacco use treatment
for those with incurable diseases.
Discussion: Although long-term benefits will not provide realistic motivation, other equally important rewards
(e.g., decreased shortness of breath), a sense of accomplishment shared by patients and family, and the ability to
exert control over a behavior can be equally motivating for some patients.
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Introduction
Patients who receive advice and assistance from theirhealthcare providers to become tobacco free achieve ab-
stinence rates significantly higher than those who do not re-
ceive such counseling.1–3 Since patients do not typically start
the conversation about their tobacco use, clinical guidelines
recommend that all providers initiate discussions about to-
bacco use with patients.1,2 Previous research examining posts
on an online cancer forum indicates that both cancer survivors
and their providers avoid initiating discussions about smoking
cessation,4 even though patients report higher satisfaction with
providers who address tobacco use and value routine support
and information from medical providers regarding treatment
options.5,6
Given the high correlation between tobacco use and cancer,
oncologists will have a significant number of patients who use
tobacco. Tobacco use (both smoked and smokeless) causes at
least 12 types of cancer, with cigarette smoking alone re-
sponsible for 30% of cancer deaths in the United States.7
Receiving a cancer diagnosis can provide a teachable moment
for addressing tobacco use.8 Yet, oncology specialists often
have neither the time nor the training to address fully the
behavioral and pharmacological components of evidence-
based tobacco treatment. In addition, there may be reluctance
to ask patients to make changes that providers feel can in-
tensify the stress and anxiety of cancer treatment. Moreover,
some providers worry they will increase the patient’s shame
or guilt, especially in the case of tobacco-related cancers, by
discussing the topic.9 If the cancer diagnosis itself does not
motivate quitting, providers may believe there is little they
can do or say that will help patients to quit.10
Interviews with patients receiving cancer treatment indi-
cate that many do appreciate their oncologists offering sup-
port in becoming tobacco free.11 Patients who receive a
cancer diagnosis are usually interested in cessation inter-
ventions and, therefore, this ‘‘teachable moment’’ can help
them achieve this goal.12–14 Since research has shown that
patients typically are ready to quit within 30 days of receiving
their diagnosis and achieve higher quit rates within the first
three months after a diagnosis, guidelines suggest offering
cessation interventions close to the time of diagnosis.13–15
Stopping all tobacco use has also been associated with im-
provements in the therapeutic ratio of anticancer therapy (i.e.,
increased efficacy and reduced treatment side effects).8,16,17
Thus, oncologists are in a unique position to promote tobacco
cessation, engage patients in intimate discussions soon after
cancer diagnoses, and craft a broad positive message to en-
courage becoming tobacco free. The American Society for
Clinical Oncology and other organizations have adopted
policy statements and guidelines reflecting the evidence for
offering treatment for tobacco use to patients with cancer.18
One unanswered question in the literature is how tobacco
cessation guidelines may best apply to oncology patients with
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We worked with Mr. R to address the psychological aspects
of his smoking using a variety of techniques, including
tracking his smoking, behavioral approaches (changing loca-
tions he kept his cigarettes or could smoke, not bringing cig-
arettes with him when he left the house, delaying smoking,
creating new routines), and stress reduction techniques (deep
breathing, stepping away from situations). Mr. R implemented
a number of these strategies and found that his smoking fluc-
tuated, often impacted by stressors in his life. Approximately
one month after his initial visit with NDP, Mr. R opted to try
the 21 mg nicotine patch for a couple of days. He did not find it
very effective and thus opted to discontinue using it. We dis-
cussed with him giving it a longer trial period to see its ef-
fectiveness and the potential value of adding in a short-acting
NRT. Mr. R periodically considered trying NRT but ultimately
would opt not to do so. Three months after his initial visit with
NDP, Mr. R was hospitalized for surgery. He intended to use
this week-long hospitalization as the start for being tobacco
free. Unfortunately, after being discharged he relapsed to
smoking. While he continued to implement behavioral strat-
egies and meet with our program on a monthly basis, he was
not consistent in his use of any tobacco cessation medication.
Six months after his initial visit with the program, Mr. R
learned that his cancer had metastasized to his lungs. Despite
this new diagnosis, Mr. R continued to be motivated to quit
smoking. He opted to purchase the nicotine lozenge and paid for
it himself, since he had been unable to get it covered by his
health insurance. Although he did not particularly care for the
taste, he used the lozenge in an effort to help reduce his smoking.
He would inconsistently use the nicotine patch along with the
nicotine lozenge. With intermittent use of recommended com-
bination NRT, Mr. R decreased his smoking to 10 cpd. Mr. R
expressed interest in trying bupropion. At that point, he was
enrolled in a clinical trial and therefore needed approval from
the study before starting the medication. While he received
approval and got a prescription for the medication, he ultimately
opted not to use it. Instead he began consistently using combi-
nation NRT and reduced his smoking to 5 cpd.
Nine months after the initial counseling session with NDP,
Mr. R successfully became tobacco free. Staying tobacco free
had its challenges, especially when he was bored, stressed, or
around people who were smoking. At various times throughout
his quit attempts, Mr. R noted some typical nicotine withdrawal
symptoms (feeling more irritable and less patient). He was open
to trying strategies such as deep breathing and using short-
acting NRT to help him during those times. Despite these
challenges and his declining health, Mr. R maintained his de-
termination to live tobacco free in the last months of his life. It
was important for him to be a positive role model for his
children, secure in the knowledge that they would remember
him as someone who did everything possible to live longer,
including becoming tobacco free. He also felt good knowing he
had accomplished something that was important to his wife.
Finally, he noted that his breathing had improved on a daily
basis, contributing to a better quality of life.
Discussion
While quitting smoking would not lead to a cure for
Mr. R’s disease, it was nonetheless important to him. His
reasons for quitting included both the significance it had for
his family and his short-term health. Even when he knew that
incurable malignancies. Medical professionals and patients 
may discount the importance of talking about becoming to-
bacco free when no cure is available or life expectancy is 
short. By not discussing the topic of tobacco cessation, the 
opportunity for a teachable moment that could have a positive 
impact on a patient’s life might be missed. This clinical report 
highlights some of the barriers and potential benefits of 
addressing tobacco cessation in patients with an incurable 
cancer diagnosis.
Case
Mr. R, a 47-year-old Caucasian male diagnosed with an 
upper tract urothelial cancer, was referred by his oncologist to 
the on-site treatment program for tobacco use, Nicotine De-
pendence Program (NDP), at the North Carolina Cancer 
Hospital’s outpatient clinic. He had smoked 1–2 packs of 
cigarettes per day (cpd) for 20 ßs. At his initial visit with the 
program’s tobacco treatment specialist, he reported smoking 
*17 cpd and expressed reluctance to quit. He felt the added 
stress of his diagnosis would make it too difficult and noted 
that some of his providers recommended that he not worry 
about quitting during this challenging time. Nonetheless, he 
verbalized several important reasons to quit smoking. (1) His 
cancer diagnosis—concerns that his smoking contributed 
to his current diagnosis and desire to prevent any future 
tobacco-related medical issues. (2) His children (both ele-
mentary school age)—wanting to be a good role model and 
ensuring that they knew he did everything possible for his 
health in the face of the cancer diagnosis. (3) His wife—who 
did not smoke and had wanted him to quit for many years. 
Mr. R recognized the challenge of attempting to quit during 
this stressful time given his cancer diagnosis; at the same 
time, he wanted to learn how to deal with stress in a different 
way and saw this as a good time to practice.
The tobacco treatment specialist worked with Mr. R to 
develop a plan that focused on behavioral support, phar-
macotherapy, and regular follow-up. As part of the initial 
assessment, we reviewed the tobacco cessation medications 
Mr. R had used during past quit attempts. Mr. R had pre-
viously tried the nicotine patch, nicotine gum, and vareni-
cline. He did not feel the nicotine patch was helpful, did not 
care for the taste of the nicotine gum, and reported feeling 
more agitated when taking varenicline. While he had pre-
viously found the nicotine patch to be ineffective, he was 
willing to try it again. We discussed the importance of using 
the appropriate dosage of nicotine replacement therapy 
(NRT) and the effectiveness of combination NRT. To-
gether, we developed the plan to first try combination NRT 
(21 mg nicotine patch and 4 mg nicotine lozenge). While 
waiting a couple of weeks to get his prescriptions filled, 
Mr. R continued to work on behavioral strategies (such as 
delaying smoking and limiting the number of cigarettes he 
could smoke.) Mr. R was unable to get the nicotine lozenge 
covered by his insurance, so he initially just got the nicotine 
patch. Mr. R did not begin using the nicotine patch right 
away, as he had been reading a book about quitting smoking 
that discouraged him from wanting to try tobacco cessation 
medication. We reviewed with him how tobacco cessation 
medication could assist with the physical nicotine with-
drawal symptoms. Mr. R decided to first focus on behav-
ioral strategies without the medication.
Table 1. Tobacco Cessation Resources for Clinicians





U.S. Department of Health and Human Services
site contains many resources, including Treating
Tobacco Use Clinical Practice Guidelines.
American Academy
of Family Physicians
www.aafp.org/home.html ‘‘Tobacco Abuse and Dependence’’ topic links to
many articles and resources for clinicians on
treatment, patient education, and more.
American Cancer Society www.cancer.org Stay Away From Tobacco campaign offers free
and up-to-date resources for patients who wish
to quit tobacco.
American Heart Association www.heart.org Helpful resources for clinicians to provide to
patients, including interactive tools such as cost
of smoking calculator and smoking quiz to raise
awareness of the dangers of tobacco and the
benefits of a nonsmoking life.
American Lung Association www.lung.org/our-initiatives/
tobacco/
Information on tobacco initiatives, including FDA
oversight of tobacco products, health insurance
coverage for cessation treatments, and more.
Association for the Treatment
of Tobacco Use and
Dependence (ATTUD)
www.attud.org ATTUD is an organization of providers dedicated
to the promotion of and increased access to
evidence-based tobacco treatment for the
tobacco user.
Become an EX www.becomeanex.org Become an EX is a free quit smoking plan with
advice from Mayo Clinic experts and a
supportive online community.
Centers for Disease Control
and Prevention
www.cdc.gov/tobacco CDC’s Office of Smoking and Health is the lead
federal agency for comprehensive tobacco
prevention and control. Website offers fact
sheets and up-to-date information about how
cigarette smoking and secondhand smoke cause
disease, disability, and death. Tips from former
smokers’ campaign feature real stories of people




www.naquitline.org Connect to quitlines in every U.S. state.
Smokefree.gov smokefree.gov Specifically geared toward individuals who wish to
quit with toolkits and resources for the





Downloadable curricula, toolkits, fact sheets,
infographics, and more for healthcare providers.
TreatTobacco.net www.treatobacco.net Hosted by the Society for Research on Nicotine
and Tobacco and the Society for the Study of
Addiction, this website provides ‘‘independent
authoritative information on the treatment of
tobacco dependence.’’
You Quit, Two Quit youquittwoquit.org Geared toward pregnant women and their families.
Resources and free training on evidence-based







A multitude of resources for those seeking more
information about MI techniques. Contains links
to the latest research on MI techniques, MI
trainings and events, and MI in the news.






Contains links to resources for incorporating MI
into various clinical modalities and webinars
about MI techniques.








Written specifically for clinicians and sponsored by
the U.S. Public Health Service and the U.S.
Department of Health and Human Services, this
document provides current and definitive clinical
practice guidelines on the treatment of tobacco
dependence.
MI, motivational interviewing.
fers insight into a specific population of cancer patients, those
with incurable malignancies and, often, shortened life ex-
pectancies. Ideally, this case study will encourage oncologists
and other providers treating incurable illnesses to consider
treatment for tobacco use in the context of the whole person,
where biopsychosocial/spiritual needs intersect. Asking pa-
tients their thoughts about becoming tobacco free and offering
supportive resources can make a difference. Within this
framework, it is never too late to engage patients in efforts to
become tobacco free.
While this case takes place in a cancer center, it can also be
relevant for offering treatment to patients with other potentially
terminal illnesses (e.g., certain cardiovascular diseases, HIV/
AIDS, end-stage renal disease.) Asking patients their thoughts
about becoming tobacco free and offering supportive resources
can make a difference. Palliative care seeks to improve quality
of life by addressing the physical, psychosocial, and spiritual
aspects of a person diagnosed with a life-threatening illness.
Offering treatment interventions for tobacco use can improve
multiple patient-centered outcomes and thus should be con-
sidered a relevant intervention for palliative care.
Please note that any identifiable information has been
changed for anonymity.
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